• Today’s clinical trial subject recruitment in Japan

    Clinical trials are fundamental for ensuring the safety and effectiveness of new medicines in real people. The entire clinical trial process involves recruiting volunteers through a careful selection process, obtaining informed consent from volunteers, testing the investigational new drugs in a controlled and carefully monitored environment, gathering and interpreting the data, and finally receiving approval to release a new drug from the Ministry of Health, Labor and Welfare.

    Recruiting patients to participate in clinical trials is one of the key links in the chain of delivering new medicines to the public, and hospitals. In Japan, as with other places around the world, there are certain barriers to timely patient recruitment which can make a clinical trial run behind schedule, costing time and money. Buzzreach provides unique solutions to overcome the challenges of patient recruitment by matching the right clinical trials with the right patients. Using the internet, our services bring clinical trial information to the public and improve the search ability of clinical trials by targeting communities of patients.

    1. 1.Issues and current status of the clinical trial market from patients’ perspective
    2. 2.Patient-related clinical trial market
    3. 3.Current status of the clinical trial patient recruitment market
    4. 4.Clinical trial sites’ patient recruitment
    5. 5.Bringing clinical trials closer
    6. 6.Contact us
    Issues and current status of the clinical trial market from patients’ perspective

    Right now, we can see many issues in the clinical trial market. The general public’s understanding of clinical trials is still fairly rudimentary, and there is a negative image surrounding medical research.

    Although there are huge numbers of clinical trials taking place in medical institutions across Japan, the information which is shared with the public is still very limited. Right now, there is no easy-access, standard place for patients, their families, and people concerned about health to search for information about clinical trials.

    Right now, more than 60% of Japanese clinical trials do not hit their target deadlines. Running overtime, increases the cost for pharmaceutical companies and delays new drug approval. Buzzreach addresses these problems by providing streamlined, easy-to-access information about participating in clinical trials to the public.

    Patient-related clinical trial market

    Many clinical trial sites and patients are involved in clinical trials in Japan. Here are the annual statistics for Japan:

    • Regardless of whether an SMO is involved or not, about 20,000 to 30,000 sites conduct clinical trials.
    • Pharmaceutical companies contract around 100,000 enrollments.
    • Clinical trial participants sign 240,000 informed consent forms.
    • o Approximately 70,000 patients actually participate in clinical trials.

    While clearly many clinical trial sites and patients are involved in clinical trials, we at Buzzreach believe there is room for improvement! We aim to foster smoother information disclosure, information sharing and information retrieval.

    Current market status of the clinical trial patient recruitment

    There are eight main patient recruitment organizations (PRO) involved in clinical trial patient recruitment in Japan, and their net worth is worth about 40 million USD and together they recruit around 6,000 patients a year.
    PROs operate on a project-by-project basis by recruiting patients for participation in specific clinical trials using their own volunteer databases. PROs only support projects which they are participating in, so the information on their websites is limited to specific diseases related to each project.
    On the other hand, the Buzzreach platform is designed to share information about the majority of studies taking place in Japan – even those not posted on PRO websites. We strive to get as much user-friendly clinical trial information to the public as possible.

    Clinical trial sites’ patient recruitment

    Although clinical trials are absolutely necessary for making sure a drug is safe and effective before it hits the market, they still have a negative image in Japan. Buzzreach aims to raise the profile of clinical trials by increasing awareness of the opportunities that they can offer patients. We provide a hub of up-to-date, relevant, and easy to understand information and education to make clinical trials more accessible to the public.
    The Buzzreach platform offers information on many different diseases, and creates and fosters communities of people who are interested in accessing clinical trial information. The matching platforms called SearchMyTrial (SMT) and Puzz allow patients and sites to connect with each other.

    Buzzreach’s platform meets a lot of different stakeholder needs:

    • Patient and their families can search for accurate and up-to-date disease and symptom information, as well as relevant clinical trial information.
    • Clinical trial sites (or SMOs) can post information about clinical trials conducted at their sites and reach specific patient communities.
    • Patient and sites can be matched with each other on the clinical trial matching platform.
    • Sponsors can access patient recruitment strategies on single platform.

    If all 20,000 – 30,000 Japanese clinical trial medical institutions use the Buzzreach platform, we are sure to see a great improvement in the quality, speed, and cost effectiveness of clinical trials in Japan, as well as huge improvements in Japan’s public image of clinical trials.

    Bringing clinical trials closer

    These days, people book flights and hotels using booking engines like Expedia. These provide the best, most relevant flight and hotel information to suits the person’s specific travel needs, such as location, schedule and budget.

    Using a similar model, Buzzreach provides relevant clinical trial information based on a patient’s needs such as diagnosis, symptoms and geographical location. Information is automatically collected from JAPIC, JMACCT, Clinical Trial Registration System, ClinicalTrials.gov, and UMIN as well as posts from clinical trial sites. Just like the popular travel search engines, Buzzreach works as a matching platform to link patients who are interested in participating in clinical trials with the most relevant sites conducting clinical trials in their region.

    Contact us

    Please inquire using the form below. We will respond as soon as possible between 9:30 and 18:30 (Monday – Friday Japan Tokyo time).

  • 日本の新薬開発における現状と課題



    1. 1.我々がサービス展開する、『患者目線』の臨床試験マーケットの課題と現状
    2. 2.臨床試験で患者に関わるマーケットは、多くの医療機関/患者と接触
    3. 3.臨床試験被験者募集に関わるマーケットの現状
    4. 4.医療機関でも治験被験者募集ができる時代
    5. 5.もっと治験(臨床試験)を身近に
    6. 6.お問い合わせ



    • 治験を含む臨床試験のイメージは、まだまだ一般の方にはグレーである。
    • 日本では多くの医療機関で臨床試験が行われているのに、情報公開量が極めて少ない。
    • 患者やその家族、健康を気にする人が臨床試験をどう探せばいいか、どう参加するか、インターネットを含めてスタンダードな手段がない。
    • 上記の課題も原因となり、日本の臨床試験は決められた期間に終えられないものが60%以上ある。
    • 決められた期間に臨床試験が終えなければ、メーカーの開発コストは上がり、新薬承認も遅くなる。




    • SMOが関与するしないに関わらず、1年間で日本で動く延べ治験実施医療機関数は、約20,000〜30,000
    • 製薬企業が上記治験実施医療機関と契約し、達成する1年間の治験契約症例数は、約100,000症例
    • 上記の治験実施医療機関で、治験に参加するために患者に同意を取る数は、約240,000名
    • 上記の治験実施医療機関で、実際に治験に参加をしている患者の数は約70,000症例






    PRO(Patient Recruitment Organization:臨床試験被験者募集機関)は製薬業界からも認知されてきている反面、プロジェクト単位でスポンサーから受注した臨床試験のみ、各社で保有するボランティアデータベースに対して被験者募集活動を行います。





    • Patient:患者やその家族は我々が提供する臨床試験マッチングプラットームで悩んでいる病気や症状を『検索』。
    • Site:臨床試験実施医療機関(またはSMO)は医療機関専用のプラットフォームに自院で実施している治験情報を『POST』。
    • Answer:我々のプラットフォーム上で患者と医療機関を『マッチング』。
    • Sponsor:スポンサーにはさまざまな被験者募集戦略をひとつのプラットフォームで提供。







    お問合せは下記のフォームにてお申し出ください。お問合せの対応は9:30~18:30(月~金)の間とさせていただきます。 内容によっては、時間がかかる場合がありますので予めご了承ください。